Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osteosarcoma in Adolescents and Young Adults”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Study completedNCT01848457
What this trial is testing

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Who this might be right for
OsteosarcomaNephrotoxicityOtotoxicity
Children's Hospital of Philadelphia 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07560826
What this trial is testing

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

Who this might be right for
Osteosarcoma in ChildrenOsteosarcoma in Adolescents and Young Adults
Wake Forest University Health Sciences 46
Not applicableActive Not RecruitingNCT03496402
What this trial is testing

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

Who this might be right for
NeuroblastomaRhabdomyosarcomaEwing Sarcoma Family of Tumors+3 more
Institut Curie 600
Early research (Phase 1)Study completedNCT03507491
What this trial is testing

Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

Who this might be right for
Cancer
Emory University 24
Testing effectiveness (Phase 2)Study completedNCT03320330
What this trial is testing

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Who this might be right for
Recurrent Malignant Solid NeoplasmRecurrent OsteosarcomaRefractory Malignant Solid Neoplasm+1 more
Children's Oncology Group 26
Testing effectiveness (Phase 2)Ended earlyNCT06341712
What this trial is testing

Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma

Who this might be right for
OsteosarcomaOsteosarcoma in ChildrenOsteosarcoma in Adolescents and Young Adults
Ipsen 10
Testing effectiveness (Phase 2)Temporarily pausedNCT04616560
What this trial is testing

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Newly Diagnosed, Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell TumorOsteosarcomaRecurrent Desmoplastic Small Round Cell Tumor+5 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)WithdrawnNCT03811886
What this trial is testing

Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma

Who this might be right for
Pulmonary Metastatic Osteosarcoma (pOS)
Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT05062707
What this trial is testing

Early Ageing During Therapy in AYA Cancer Patients

Who this might be right for
CancerLeukemiaHodgkin Lymphoma+5 more
University Medical Center Groningen 120
Testing effectiveness (Phase 2)Study completedNCT05093322
What this trial is testing

Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Solid TumorLymphomaOsteosarcoma+3 more
Hutchmed 13
Not applicableEnrolling By InvitationNCT06737172
What this trial is testing

Functional and Structural Outcomes Following Childhood Bone or Soft Tissue Sarcomas of the Lower Extremity

Who this might be right for
Soft Tissue Sarcoma of the Lower ExtremityBone Sarcoma of the Lower ExtremityChildhood and Adolescent Cancer
Technical University of Munich 18
Testing effectiveness (Phase 2)Looking for participantsNCT06709495
What this trial is testing

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Who this might be right for
SarcomaSarcoma, EwingDesmoplastic Small Round Cell Tumor+3 more
David S Shulman, MD 63
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02945800
What this trial is testing

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Who this might be right for
OsteosarcomaEwing SarcomaRhabdomyosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 59
Testing effectiveness (Phase 2)Looking for participantsNCT06625190
What this trial is testing

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaSynovial Sarcoma+10 more
University of Florida 27
Testing effectiveness (Phase 2)Study completedNCT02432274
What this trial is testing

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Who this might be right for
TumorsSolid Malignant TumorsOsteosarcoma+1 more
Eisai Limited 117
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Early research (Phase 1)Ended earlyNCT02536183
What this trial is testing

A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors

Who this might be right for
Pediatric CancerSolid TumorsRhabdomyosarcoma+7 more
AeRang Kim 2
Testing effectiveness (Phase 2)Ended earlyNCT04897880
What this trial is testing

Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT

Who this might be right for
Rhabdoid TumorAtypical Teratoid/Rhabdoid TumorMalignant Rhabdoid Tumor+1 more
Australian & New Zealand Children's Haematology/Oncology Group 25
Not applicableStudy completedNCT04248959
What this trial is testing

Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas

Who this might be right for
Sarcoma,Soft TissueOsteosarcoma
University Health Network, Toronto 7
Load More Results